Corporate Governance Statement
Principles of Corporate Governance
Compliance with the QCA Code is set out in broad terms below. Annual updates on compliance will be provided.
Principle 1: Establish a strategy and business model which promote long-term value for shareholders
Principle 2: Seek to understand and meet shareholder needs and expectations
Principle 3: Take in account wider stakeholder and social responsibilities and their implications for long-term success
Principle 4: Embed effective risk management, considering both opportunities and threats, throughout the organisation
MAINTAIN A DYNAMIC MANAGEMENT FRAMEWORK
Principle 5: Maintaining the board as a well-functioning, balanced team led by the Chair
Principle 6: Ensure that between them the directors have the necessary up to date skills and capabilities
Principle 7: Evaluate board performance based on clear and relevant objectives, seeking continuous improvement
Principle 8: Promote a culture that is based on ethical values and behaviours
Principle 9: Maintain governance structures and processes that are fit for purpose and support good decision-making by the board
Principle 10: Communicate how the company is governed and is performing by maintaining a dialogue with shareholders and other relevant stakeholders
The company discloses all relevant information in its annual report, copies of which are available on the company website along with governance related information issued from the date of admission to trading on AIM (www.fusionantibodies.com).
The company also discloses the outcomes of votes at general meetings, and where more than 20% of independent votes have been cast against a resolution at any general meeting the company will indicate its actions to understand the reason for that vote and any decisions or actions taken as a result.
For the most recent voting results click Annual & Half Year Reports